
zzso inflammatory functions may be critical factors in the mechanisms of severe zzso disorders classified as the human zzso zzso zzso zzso zzso Evidence indicates that a viral gene product, the zzso of zzso protein zzso can markedly contribute to these zzso We zzso report that zzso zzso zzso a novel zzso zzso syndrome drug candidate now in a phase II clinical trial, significantly reversed zzso release of zzso zzso zzso necrosis factor zzso zzso zzso and zzso and dose zzso decreased the zzso of zzso oxygen species and zzso oxide in zzso zzso Furthermore, zzso zzso arrested zzso protein zzso C zzso zzso zzso and blocked the downstream zzso regulated zzso zzso and zzso zzso zzso zzso zzso These molecular mechanisms could be attributed to the fact that zzso zzso bound to the basic domain zzso acids zzso of the zzso protein with high affinity zzso approximately zzso zzso zzso zzso leading to zzso of zzso zzso and zzso These data demonstrate that zzso might serve as a valuable therapeutic intervention for zzso profound zzso effects in the brain, and subsequent zzso events of zzso 

